An American medical physicist who received the Nobel Prize in Physiology or Medicine for the development of the radioimmunoassay for insulin in 1977.

Developed the field of obstetric diabetes.

Executive Director of Diabetes Canada and an advocate for better diabetes care.

A patient-oriented researcher living with type 1 diabetes.

A digital health innovator who is revolutionizing the way we study, manage and care for diabetes.

Researching better health outcomes for pregnant people living with diabetes.

Uncovering how and why insulin resistance develops in type 2 diabetes.

President and Science Director at the Gairdner Foundation whose early developmental biology research was supported by the Banting Research Foundation.

Endocrinologist and former CEO of Diabetes Canada who developed the algorithm that determined how many people in Canada live with diabetes.

Canada’s top doctor is also an ardent advocate for diabetes prevention and has worked tirelessly towards creating supportive environments that foster positive changes for people susceptible to diabetes.

Recipient of a Banting Research Foundation grant, which helped launch her distinguished research career exploring and expanding healthcare provided to retinoblastoma patients.

Nurse and founder of the Charles H. Best Diabetes Centre.

A nurse and diabetes educator who has worked tirelessly to support diabetes patients facing housing insecurity.

Interdisciplinary researcher whose work revealed a key role of the immune system in diabetes.

Epidemiologist whose research on population health management and diabetes is revolutionizing prevention strategies, and improving health decision-making and intervention for populations at risk for type 2 diabetes and other chronic conditions.

Documented some of Canada’s first cases of type 2 diabetes in children in the late 1980s.

Working to understand risk factors associated with Type 1 diabetes and how to reduce its burden in her province of Newfoundland and Labrador.

Researching the autotaxin-LPA pathway and how the components involved may lead to obesity-related type 2 diabetes.

Nephrologist, Chair of the Board of the Banting Research Foundation and Executive Director of Diabetes Action Canada.

Pharmacist, knowledge mobilizer and leader in diabetes education.